Barry M. Bredt - Concepedia

Concepedia

Author

Barry M. Bredt

University of California, San Francisco

Also Known As

B. Bredt, B.M. Bredt, Barry Bredt, Barry M Bredt, Barry M. Bredt, Barry M. Bredt, William R. Freeman

26

Publications

3.4K

Citations

21

H-Index

26

Concepts

All Affiliations

University of California, San Francisco San Francisco General Hospital BD Biosciences (United States)Gladstone Institutes San Francisco AIDS Foundation

BM

About

Barry M. Bredt is an author at University of California, San Francisco specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.2K
2	Immunology	8	8	1.2K
3	Cell Biology	2	2	384
4	Allergy	1	1	228
5	Neurology	1	1	32

Barry M. Bredt

×

21

Publications

3.4K

Citations

21

H-Index

	Year	Citations
T Cell Activation Is Associated with Lower CD4<sup>+</sup>T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy Peter W. Hunt, Jeffrey N. Martin, Elizabeth Sinclair, The Journal of Infectious Diseases	2003	845
Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1 Krishna V. Komanduri, Mohan Viswanathan, Eric Wieder, Nature Medicine Viral PersistenceHuman RetrovirusImmunologyActive Antiretroviral TherapyAntiviral Response	1998	396
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry Holden T. Maecker, Holli S Dunn, Maria Suni, Journal of Immunological Methods InflammationAutoimmune DiseasePeptide MixturesMedicineCytokine Flow Cytometry	2001	350
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses Priscilla Y. Hsue, Peter W. Hunt, Elizabeth Sinclair, AIDS	2006	277
HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes Michelle E. Roland, Burc Barin, Luke Carlson, American Journal of Transplantation	2008	243
Standardization of cytokine flow cytometry assays Holden T. Maecker, Aline Rinfret, Patricia D’Souza, BMC Immunology	2005	238
Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection Donald I. Abrams, Joan F. Hilton, Roslyn J. Leiser, Annals of Internal Medicine	2003	230
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells Annika C. Karlsson, Jeffrey N. Martin, Sophie R. Younger, Journal of Immunological Methods Flow Cytometry AssaysAllergyAutoimmune DiseaseLaboratory ImmunologyT-regulatory Cell	2003	228
Strong Cell‐Mediated Immune Responses Are Associated with the Maintenance of Low‐Level Viremia in Antiretroviral–Treated Individuals with Drug‐Resistant Human Immunodeficiency Virus Type 1 Steven G. Deeks, Jeffrey N. Martin, Elizabeth Sinclair, The Journal of Infectious Diseases	2004	88
Short‐Term Effects of Cannabinoids on Immune Phenotype and Function in HIV‐1‐Infected Patients Barry M. Bredt, Dana Higuera‐Alhino, Starley B. Shade, The Journal of Clinical Pharmacology	2002	73

Page 1